drug delivery

A new microrobot uses algae to transport antibiotics into the lungs of mice with pneumonia.

Microscopic algae dotted with drug-filled nanoparticles may offer a more effective means of treatment than traditional delivery methods.

By packaging lipid nanoparticles with elements that decrease the fibrous nature of solid tumors, researchers can deliver CRISPR therapies in a more efficient manner.

A vaccine strategy involving formulation changes, an initial escalating dose, and a longer wait for booster immunization results in more-effective antibody production against HIV in rhesus monkeys, a study finds.

Research on microneedle patches for vaccine delivery has grown in popularity in recent years, due to their exceptional compliance and low invasiveness.

RNA-DNA complexes that were modified with cholesterol made it into the brains of rats and mice, where they knocked down target genes.

A study has sparked controversy by suggesting that cells made using a popular lab protocol have been misidentified, with potentially serious repercussions for brain research. Critics say the significance of the findings has been overstated.

Researchers are engineering microbes to deliver therapeutics specifically to tumors, maximizing the treatments’ efficacy while minimizing side effects.

Autonomous, living microrobots that seek and destroy cancer are not as futuristic as one might imagine, thanks to a fusion of robotics and synthetic biology.

Researchers could one day use the method to deliver antibiotics to topical wounds infected by hard-to-treat masses of bacteria.

DNA-responsive polymer gels used for releasing drugs, encapsulating cells, and much more now have greater adaptability thanks to the Cas12a nuclease.

The US Food and Drug Administration halts a study by Solid Biosciences after a patient experiences severe side effects following treatment.

A device implanted into mice can modulate brain circuit activity over long periods of time.

A microneedle delivers liquid medicines through tiny, fang-like points.

An injectable biomaterial calls cancer drugs to tumor sites in mice.

Lonza will employ more than 200 full-time staff to work at the Texas-based facility, the company says.